WOOJUNG BIO, Inc. (KOSDAQ:215380)
South Korea
· Delayed Price · Currency is KRW 1,473.00
-19.00 (-1.27%)
Mar 18, 2025, 9:00 AM KST
WOOJUNG BIO Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 225.3 | -5,054 | -1,880 | -1,926 | -10,879 | Upgrade
|
| Depreciation & Amortization | 4,202 | 4,323 | 4,247 | 2,701 | 1,586 | Upgrade
|
| Loss (Gain) From Sale of Assets | 48.6 | -27.2 | 61.77 | 53.59 | 16.01 | Upgrade
|
| Asset Writedown & Restructuring Costs | -560.38 | - | - | - | 3.06 | Upgrade
|
| Loss (Gain) From Sale of Investments | 50.13 | -5.51 | 875.87 | -1,182 | -40.82 | Upgrade
|
| Loss (Gain) on Equity Investments | 3 | - | - | - | - | Upgrade
|
| Stock-Based Compensation | - | - | - | - | 70 | Upgrade
|
| Provision & Write-off of Bad Debts | -283.78 | -483.71 | -188.85 | -278.63 | 2,284 | Upgrade
|
| Other Operating Activities | -1,688 | 436.36 | -1,261 | -401.15 | 6,140 | Upgrade
|
| Change in Accounts Receivable | 956.46 | -4,442 | 3,499 | -732.74 | -2,241 | Upgrade
|
| Change in Inventory | 38.75 | -424.43 | 1,177 | -474.57 | 829.16 | Upgrade
|
| Change in Accounts Payable | 1,952 | -269.69 | -148.15 | 349.66 | -603.59 | Upgrade
|
| Change in Income Taxes | - | - | -11.68 | -22.01 | - | Upgrade
|
| Change in Other Net Operating Assets | -6,070 | 2,725 | -3,869 | 3,640 | -5,738 | Upgrade
|
| Operating Cash Flow | -1,126 | -3,222 | 2,502 | 1,728 | -8,575 | Upgrade
|
| Operating Cash Flow Growth | - | - | 44.82% | - | - | Upgrade
|
| Capital Expenditures | -292.45 | -842.88 | -11,422 | -36,684 | -15,765 | Upgrade
|
| Sale of Property, Plant & Equipment | 101.52 | 80.64 | 344.56 | 72.77 | 10 | Upgrade
|
| Sale (Purchase) of Intangibles | -17.06 | -51.36 | -87.97 | 54.36 | -873.62 | Upgrade
|
| Investment in Securities | -882.87 | 880.31 | 4,830 | 6,891 | -1,592 | Upgrade
|
| Other Investing Activities | 43.18 | 69.16 | 148.55 | 228.64 | - | Upgrade
|
| Investing Cash Flow | -1,048 | 135.86 | -6,187 | -29,437 | -18,221 | Upgrade
|
| Short-Term Debt Issued | 2,439 | 12,700 | 8,581 | 3,700 | 8,002 | Upgrade
|
| Long-Term Debt Issued | 30,000 | 14,313 | - | 24,000 | 16,000 | Upgrade
|
| Total Debt Issued | 32,439 | 27,013 | 8,581 | 27,700 | 24,002 | Upgrade
|
| Short-Term Debt Repaid | -10,357 | -5,830 | -10,099 | -2,785 | -800 | Upgrade
|
| Long-Term Debt Repaid | -23,534 | -16,285 | -545.31 | -1,032 | -1,775 | Upgrade
|
| Total Debt Repaid | -33,892 | -22,115 | -10,645 | -3,817 | -2,575 | Upgrade
|
| Net Debt Issued (Repaid) | -1,453 | 4,898 | -2,064 | 23,883 | 21,426 | Upgrade
|
| Issuance of Common Stock | 2,043 | - | - | - | - | Upgrade
|
| Other Financing Activities | 186.05 | 27.36 | -345.79 | 172.78 | -174.13 | Upgrade
|
| Financing Cash Flow | 775.92 | 4,925 | 6,807 | 24,056 | 26,252 | Upgrade
|
| Foreign Exchange Rate Adjustments | 1.11 | 0.66 | -1.36 | -0.44 | -52.88 | Upgrade
|
| Net Cash Flow | -1,397 | 1,840 | 3,122 | -3,653 | -596.41 | Upgrade
|
| Free Cash Flow | -1,419 | -4,065 | -8,919 | -34,956 | -24,340 | Upgrade
|
| Free Cash Flow Margin | -3.28% | -10.53% | -19.01% | -111.90% | -65.18% | Upgrade
|
| Free Cash Flow Per Share | -94.47 | -317.71 | -690.40 | -2922.44 | -2103.16 | Upgrade
|
| Cash Interest Paid | 2,562 | 2,347 | 1,217 | 813.03 | 298.25 | Upgrade
|
| Cash Income Tax Paid | -3.69 | -5.93 | -7.35 | -7.21 | 8.97 | Upgrade
|
| Levered Free Cash Flow | -7,219 | -8,994 | -5,372 | -24,716 | -25,027 | Upgrade
|
| Unlevered Free Cash Flow | -5,202 | -6,979 | -3,624 | -24,311 | -24,993 | Upgrade
|
| Change in Net Working Capital | 10,209 | 7,892 | -5,215 | -12,031 | 6,632 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.